Amgen Inc. buy UBS Group AG
Start price
26.01.26
/
50%
€293.05
Target price
26.01.27
-
Performance (%)
24.21%
Price
14.08.26
€358.95
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG currently has a performance of 24.21%. Dividends of €5.04 are taken into consideration when calculating the performance. This prediction currently runs until 26.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.999% | 0.999% |
| iShares Core DAX® | 0,44 % | 5,64 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by UBS_Group_AG for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for AMGN provided by MarketBeat